PreSENTIA NIPD GENETICS hereditary cancer Logo (WIPO, 25.06.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke PreSENTIA NIPD GENETICS hereditary cancer wurde als Bildmarke am 25.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1544804 |
| Registernummer | 018083687 |
| Länder | 
|
| Basismarke |
Nr. 018083687,
09. November 2019
|
| Anmeldedatum | 25. Juni 2020 |
| Ablaufdatum | 25. Juni 2030 |
Markeninhaber
31, Neas Engomis, Engomi
2409 Nicosia
CY
2409 Nicosia
CY
Markenvertreter
2-4, Arch. Makaros III Avenue,
Capital Center, 7th floor
CY
Waren und Dienstleistungen
01
Kits and reagents for genetic testing for medical and
scientific research purposes in the field of cancer
detection; kits and reagents for cancer testing for medical
and scientific research purposes; nucleic acid based kits
and reagents for testing cancer diseases for medical and
scientific research purposes
42
Medical laboratory services for testing of cancer and cancer
prevention; design and development of medical diagnostic
tests and products; medical and scientific research in the
field of genetic testing; providing medical and scientific
research information in the field of genetic testing;
genetic testing for scientific research and analysis
purposes in the field of cancer detection; genetic
engineering services; scientific, laboratory, clinical,
medical, and technological research and analysis services in
the fields of nucleic acid analysis, cancer testing, and
genetics; scientific research for medical purposes in the
area of cancerous diseases
44
Medical analysis services for the diagnosis and prognosis of
cancer; medical genetic testing services for diagnosis,
prevention and treatment of cancer; medical testing of blood
for diagnosis of cancer; genetic testing and genetic
counseling in the field of cancer detection; medical and
health services relating to DNA and genetics testing; RNA or
DNA analysis for cancer diagnosis and prognosis
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 27. Januar 2022 | 2022/5 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. August 2021 | 2021/31 Gaz | JP | Ablehnung |
| 07. April 2021 | 2021/16 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. Oktober 2020 | 2020/43 Gaz | SG | Ablehnung |
| 25. Juni 2020 | 2020/30 Gaz | EM | Eintragung |
ID: 141544804